This might be of interest, April 11 - Italian diagnostics group DiaSorin SpA DIAS.MI said on Sunday it will acquire U.S. based Luminex Corp LMNX.O for $1.8 billion in an all-cash deal that will strengthen DiaSorin's molecular diagnostics technology.
Liam, you might find at the end of day the correct price is shown. Mine on interactive investors do this. Think it is due to the shares being on Aquis stock exchange rather than the LSE AIM.
Maybe the directors could be selling some shares now,crystallising a capital gain this tax year.With a view to buying shares back latter. These shares would then have a reduced gain in following years. This might be a good strategy if they expect tax rates to go up next year, along with a good rise in the share price. As the sells are pushing the share price down it could be very profitable if timed right.